Rozamus; Leonard W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rozamus; Leonard W..The latest application filed is for "pharmaceutical formulations comprising 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine".

Company Profile

6.18.25

Rozamus; Leonard W. - Andover MA
Rozamus; Leonard W. - Bedford MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine Grant 11,427,605 - Rozamus , et al. August 30, 2	2022-08-30
Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine App 20220249524 - Verwijs; Dauntel S. ; et al.	2022-08-11
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 11,384,086 - Murray , et al. July 12, 2	2022-07-12
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 11,279,705 - Murray , et al. March 22, 2	2022-03-22
Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine App 20210401860 - Verwijs; Dauntel S. ; et al.	2021-12-30
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 11,192,896 - Murray , et al. December 7, 2	2021-12-07
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 11,192,895 - Murray , et al. December 7, 2	2021-12-07
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 11,192,897 - Murray , et al. December 7, 2	2021-12-07
Crystalline Forms Of 5-chloro-n4-[-2-(dimethylphosphoryl) Phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) Piperidin-1-yl] Phenyl} Pyrimidine-2,4-diamine App 20210355146 - Rozamus; Leonard W. ; et al.	2021-11-18
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide And Its Mono Hydrochloride Salt App 20210340149 - Murray; Christopher K. ; et al.	2021-11-04
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide And Its Mono Hydrochloride Salt App 20210277011 - Murray; Christopher K. ; et al.	2021-09-09
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide And Its Mono Hydrochloride Salt App 20210277010 - Murray; Christopher K. ; et al.	2021-09-09
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide And Its Mono Hydrochloride Salt App 20210277012 - Murray; Christopher K. ; et al.	2021-09-09
Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine App 20210186994 - Verwijs; Dauntel S. ; et al.	2021-06-24
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine Grant 10,934,317 - Rozamus , et al. March 2, 2	2021-03-02
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide And Its Mono Hydrochloride Salt App 20210024527 - Murray; Christopher K. ; et al.	2021-01-28
Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 10,662,197 - Murray , et al.	2020-05-26
Crystalline Forms Of 5-chloro-n4-[-2-(dimethylphosphoryl) Phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) Piperidin-1-yl] Py App 20200010493 - Rozamus; Leonard W. ; et al.	2020-01-09
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylp- iperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine Grant 10,385,078 - Rozamus , et al. A	2019-08-20
Crystalline Forms Of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin- -1-yl)methyl]-3-(trifluoromethyl App 20190169196 - Murray; Christopher K. ; et al.	2019-06-06
Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(- trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 10,125,136 - Murray , et al. November 13, 2	2018-11-13
Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpi- perazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine App 20180256610 - Verwijs; Dauntel S. ; et al.	2018-09-13
Crystalline Forms Of 5-chloro-n4-[-2-(dimethylphosphoryl) Phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) Piperidin-1-yl] Pyrimidine-2,4-diamine App 20180037597 - ROZAMUS; Leonard W. ; et al.	2018-02-08
Crystalline Forms Of 3-(imidazo[1,2-b] Pyridazin-3-ylethynyl)-4-methyl-n-benzamide And Its Mono Hydrochloride Salt App 20170190707 - Murray; Christopher K. ; et al.	2017-07-06
Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt Grant 9,493,470 - Murray , et al. November 15, 2	2016-11-15
Crystalline Forms Of 3-(imidazo[1,2-b] Pyridazin-3-ylethynyl)-4-methyl-n-benzamide And Its Mono Hydrochloride Salt App 20150315194 - Murray; Christopher K. ; et al.	2015-11-05
Phosphorus-containing compounds and uses thereof Grant 9,024,014 - Berstein , et al. May 5, 2	2015-05-05
Phosphorus-containing Compounds & Uses Thereof App 20120178714 - Berstein; David L. ; et al.	2012-07-12
Phosphorus-containing compounds and uses thereof Grant 8,058,426 - Berstein , et al. November 15, 2	2011-11-15
Phosphorus-containing compounds & uses thereof App 20100197907 - Berstein; David L. ; et al.	2010-08-05
Implantable device comprising phosphorus-containing macrolides Grant 7,709,020 - Berstein , et al. May 4, 2	2010-05-04
Phosphorus-containing macrocycles Grant 7,432,277 - Metcalf, III , et al. October 7, 2	2008-10-07
Phosphorus-containing compounds & uses thereof App 20070190106 - Berstein; David L. ; et al.	2007-08-16
Phosphorus-containing compounds and uses thereof Grant 7,186,826 - Metcalf, III , et al. March 6, 2	2007-03-06
Phosphorus-containing macrocycles App 20060264405 - Metcalf; Chester A. III ; et al.	2006-11-23
Phosphorus-containing compounds & uses thereof App 20060264456 - Metcalf; Chester A. III ; et al.	2006-11-23
Therapies for treating disorders of the eye App 20060247265 - Clackson; Timothy P. ; et al.	2006-11-02
Phosphorus-containing compounds and uses thereof Grant 7,091,213 - Metcalf, lll , et al. August 15, 2	2006-08-15
Phosphorus-containing compounds and uses thereof App 20050032825 - Metcalf, Chester A. III ; et al.	2005-02-10
Phosphorus-containing macrocycles App 20050026868 - Metcalf, Chester A. III ; et al.	2005-02-03
Phosphorus-containing compounds and uses thereof App 20040073024 - Metcalf, Chester A. III ; et al.	2004-04-15
Phosphorus-containing compounds and uses thereof App 20030220297 - Berstein, David L. ; et al.	2003-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.